BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CiviCRM//NONSGML CiviEvent iCal//EN
X-WR-TIMEZONE:Europe/London
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261209T083000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:CiviCRM_EventID_2019_e86a4f28f24ec85011f2b11344e0bb4c@onenucleus.com
SUMMARY:Developing an Effective Innovation Investment Stra
 tegy
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC
  "-//W3C//DTD HTML 3.2//EN"><html><body><p>The tra
 nslation of bio-innovation into novel healthcare p
 roducts and technologies to improve patient outcom
 es is completely reliant on securing sufficient in
 vestment. Whilst many will argue investment trends
  are cyclical\, this has been a challenging financ
 ing environment\, particularly at the early stages
  of development for a very extended period. As a c
 onsequence\, bio-entrepreneurs are having to be fl
 exible in the types\, geographies and cost of capi
 tal\, but the underlying need for a robust\, well-
 protected innovation remains critical. Kindly host
 ed by Mathys & Squire\, the session will discuss w
 hat a modern-day innovation investment strategy re
 quires. </p>\n \n <p><img alt="image-2026102811235
 7-1.jpeg" src="https://onenucleus.com/sites/defaul
 t/files/civicrm/persist/contribute/images/image-20
 261028112357-1.jpeg" style="width:270px\;height:48
 px\;" /> <br />\n <br />\n <strong>Agenda:</strong
 ><br />\n 08.30 – Arrival and Networking<br />\n 0
 9.15 – Welcome<br />\n 09.20 – Trends in global IP
  strategies to maximise investor attraction<br />\
 n           Craig Titmus\, Partner and Martin McLe
 an\, Partner\, Mathys & Squire<br />\n 09.30 – Acc
 essing non-dilutive funding <br />\n           Spe
 aker tbc<br />\n 09.40 – Navigating the de-risking
  stack<br />\n           Speaker tbc<br />\n 09.50
  – Short company pitches and Q&A<br />\n 10.30 – N
 etworking<br />\n 11.00 – Close</p>\n \n <p><stron
 g>Registration:</strong><br />\n This event is ope
 n to attendees from the following organisation typ
 es: <br />\n •    Companies undertaking R&D in the
  life science companies <br />\n •    Investors an
 d analysts<br />\n •    Product development advise
 rs<br />\n •    Technology Transfer Offices<br />\
 n •    Policy makers<br />\n •    Translational re
 search academics<br />\n •    Media</p>\n \n <p><s
 trong>Attendance is by <u>invitation only</u> with
  limited capacity. To request an invitation please
  email Tony Jones at <a href="mailto:tony@onenucle
 us.com">tony@onenucleus.com</a>.</strong></p></bod
 y></html>
DESCRIPTION:The translation of bio-innovation into novel healt
 hcare products and technologies to improve patient
  outcomes is completely reliant on securing suffic
 ient investment. Whilst many will argue investment
  trends are cyclical\, this has been a challenging
  financing environment\, particularly at the early
  stages of development for a very extended period.
  As a consequence\, bio-entrepreneurs are having t
 o be flexible in the types\, geographies and cost 
 of capital\, but the underlying need for a robust\
 , well-protected innovation remains critical. Kind
 ly hosted by Mathys & Squire\, the session will di
 scuss what a modern-day innovation investment stra
 tegy requires. \n \n \n \n  \n \n \n \n Agenda:\n 
 \n 08.30 – Arrival and Networking\n \n 09.15 – Wel
 come\n \n 09.20 – Trends in global IP strategies t
 o maximise investor attraction\n \n           Crai
 g Titmus\, Partner and Martin McLean\, Partner\, M
 athys & Squire\n \n 09.30 – Accessing non-dilutive
  funding \n \n           Speaker tbc\n \n 09.40 – 
 Navigating the de-risking stack\n \n           Spe
 aker tbc\n \n 09.50 – Short company pitches and Q&
 A\n \n 10.30 – Networking\n \n 11.00 – Close\n \n 
 \n \n Registration:\n \n This event is open to att
 endees from the following organisation types: \n \
 n •    Companies undertaking R&D in the life scien
 ce companies \n \n •    Investors and analysts\n \
 n •    Product development advisers\n \n •    Tech
 nology Transfer Offices\n \n •    Policy makers\n 
 \n •    Translational research academics\n \n •   
  Media\n \n \n \n Attendance is by invitation only
  with limited capacity. To request an invitation p
 lease email Tony Jones at tony@onenucleus.com (mai
 lto:tony@onenucleus.com).\n \n 
CATEGORIES:Events
CALSCALE:GREGORIAN
DTSTAMP;TZID=Europe/London:20261209T083000
DTSTART;TZID=Europe/London:20261209T083000
DTEND;TZID=Europe/London:20261209T110000
LOCATION:Mathys & Squire LLP\n The Shard\n 32 London Bridge
  Street\n London\, SE1 9SG\n United Kingdom\n 
URL:https://onenucleus.com/civicrm/event/info?reset=1&id=2019
END:VEVENT
END:VCALENDAR